Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress?. 2006 114:1063-69Ĭohen S, Springer C, Avital A, Perles Z, Rein A, Argaman Z, et al. B-type natriuretic peptide predicts adverse cardiovascular systolic dysfunction. Price JF, Thomas AK, Grenier M, Eidem BW, Smith OB, Denfield SW, et al. Brain natriuretic peptide (BNP)- a marker of new millennium in diagnosis of congestive heart failure. Raizada A, Bhandari S, Khan MA, Singh HV, Thomas S, Sarabhai N, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. The natriuretic peptide system : Kidney and cardiovascular effect. B-type natriuretic peptide measurement in heart failure. B-type natriuretic peptide: a review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians. In NTproBNP as a biomarker in cardiovascular disease. NT-proBNP biology : How is it made, what is circulating and what exactly are we measuring?. Fungsi Endokrin Ginjal, Jantung, dan Kelenjar Pineal. 2002 110:1-6ī-type natriuretic peptide (BNP) assay. Plasma concentrations of N-Terminal pro-Brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Mir ST, Marohn S, Laer S, Eislt M, Grollmus O, Weil J.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |